New program at Sunnybrook Hospital shortens waiting times for prostate cancer diagnoses!
March 31, 2011
Original article from CTV.ca News Staff
A Toronto hospital says it’s setting what it hopes is a new benchmark for telling men whether they have prostate cancer.
Instead of giving men their biopsy results in a matter of weeks, they receive them in just 72 hours. Read more
Prostate Cancer: To the biopsy and beyond
March 30, 2011
Dr. Roger Buckley, Medical Director, Gale and Graham Wright Prostate Centre and Chief of Urology
Dr. Denis MacDonald, Chief Pathologist and Director of Laboratories, Department of Laboratory Medicine
Dr. Irv Jacobs, Chief of Radiography Department
North York General Hospital
The Gale and Graham Wright Prostate Centre
CLICK ON THE BLUE TEXT BELOW, TO SEE OUR VIDEOS
Dr. Robert Bristow “Personalized Medicine in Prostate Cancer”
January 26, 2011
On Jan. 26, 2011 Dr. Robert Bristow, gave details of a International Reseach project to PCCN-Toronto’s Awareness Night, prior to it’s public announcement
-The study of cancer genetics is unlocking the secrets of prostate cancer
-These secrets will give rise to new diagnostic tests and new treatments within the next 10 years.
-These will be personal secrets that can be used to individualize treatment for men with prostate cancer.
-and more
Feb. 15, 2011 from CBC News
“Prostate cancer genome to be decoded”
Prostate cancer’s genetic mutations will be mapped under a new $20 million Canadian research project that aims to eventually improve diagnosis and treatment of the disease.
READ MORE
Click here for Dr. Bristow introduction by Winston Klass
Click here for Video Part 1
Click here for Video Part 2
Click here for Video Part 3
Click here for Video Part 4
Click here for complete video.
Click here for Dr. Bristow’s Bio.
Click here for Dr. Bristow Answers Questions
Dr. Bristow Answers Questions
January 25, 2011
Click for questionDrugs or clinical trials for Cancer that seems hormone resistant?
Click for questionWhat has been done to find the cause of cancer?
Click for questionDoes an enlarged prostate lead to prostate cancer?
Click for questionDoes aggresive mean fast growing?
Click for questionPt. 1 Spot in pelvic area?
Click for questionPt. 2 Would he be a candidate for Tookad?
Click for questionDefect in cellular repair?
Click for questionCompare surgery and radio therapy? How many newly diagnosed in GTA? more
Click for questionConnection between your research and urine test?
Click for questionIs the Protein PML part of your work?
Click for questionHow is thiis work funded?
Click for questionWould unlimited funds accelerate the program?
Click for questionIs the project prostate specific?
Click for questionWhat can be expected in the future?
Awareness – our December 2010 Newsletter
December 29, 2010
CLICK ON THE BLUE TEXT BELOW TO READ OUR LATEST NEWSLETTER
PCCN Toronto Newsletter December 2010
In this Issue:
- . Dr. Andrew Matthew a big hit and first speaker to be videotaped
· 2010 National Prostate Cancer Conference – see photos
· First-ever Ladies’ Forum very successful
· A Special Tribute to out-going chairman Aaron Bacher
· PCCN-Toronto participates in PCC’s Walk/Run for Dad
· PCCN-Toronto suffers two huge losses – Sol Dennis and Mark Dailey
· A message from our new chairman
You will need Adobe Reader 6 or higher to read our newsletters
Click here for Adobe Reader
Dr. Andrew Matthew “The Psychological Aspect of Prostate Cancer”
November 24, 2010
Below, is the Full Presentation, 32 minutes long, which due to server restrictions, is Standard Definition.
Below that, there is a High Definition (HD) version which is in 4 parts.
——————————————————————————
Dr. Andrew Matthew is a staff Psychologist at Princess Margaret Hospital. He is a Clinician-Investigator in the Department of Surgery, Division of Urology, and a member of the Department of Psychosocial Oncology and Palliative Care. He is also an Assistant Professor in the Faculty of Medicine, University of Toronto, in the Departments of Surgery and Psychiatry.
Since 1993, he has worked in health psychology.
Dr. Matthew’s current clinical/research focus involves all urologic cancers (Prostate, Testicular, Bladder, and Kidney) and includes prostate cancer prevention, treatment decision-making, sexual rehabilitation and patient quality of life. He co-developed the Princess Margaret Hospital Prostate Cancer Rehabilitation Clinic/Program designed to assist couples adapt to sexual changes and urinary incontinence post cancer treatment.
Dr. Matthew has a private practice, Clear Path Solutions, located in downtown Toronto.
Dr. Matthew, his wife and three young sons live in Toronto.
Full Version, 32 minutes, Standard Definition
High Definition (HD) version in 4 parts
Part 1 7 minutes 56 seconds
Part 2 8 minutes 40 seconds
Part 3 8 minutes
Part 4 7 minutes 20 seconds
A Special Tribute to Aaron Bacher
November 24, 2010
Aaron Bacher steps down after 8 1/2 Years as Chairman of “Man to Man” now “PCCN-Toronto”
Honours follow from Aaron’s friends and associates.
Below is the Full Presentation, 42 minutes long, which due to server restrictions, is Standard Definition.
Below that there is a High Definition (HD) version which is in 6 parts.
——————————————————————————————–
Full Version, 42 Minutes, Standard Definition
High Definition (HD) version in 6 parts
Winston Klass, Vice Chairman, PCCN-Toronto 12 minutes 21 seconds
Pearse Murray. Director, PCCN-Toronto 4 minutes 27 seconds
Helene Vassos and Steve Jones, Prostate Cancer Canada Under 7 minutes
Dr. Gerard Morton 3 minutes 39 seconds
Ron Benson, Chairman, PCCN-Toronto 4 minutes 41 seconds
Aaron Bacher, Immediate Past Chairman, PCCN-Toronto 8 minutes
Dr. Andrew Matthew, Staff Psychologist, Princess Margaret Hospital 2 minutes 50 seconds
Team touts cancer ‘lab on a chip’
October 8, 2009
(M2M comment- Dr. Aaron Wheeler at the Canadian Cancer Society Innovative Research in Cancer Event, Sept. 23, 2009, showed a similar device he is developing to detect Prostate Cancer.)
Joseph Hall HEALTH REPORTER TORONTO STAR
Aaron Wheeler holds a petri dish bearing a lump of breast tissue that resembles, in size and appearance, a piece of chewed gum.
In his right, the University of Toronto chemist holds a microchip array, about the size of a credit card, bearing a drop of red liquid about a thousand times smaller than the glob of flesh. The drop represents the minute amount of cells that Wheeler’s tiny board needs to accurately gauge estrogen levels in a woman’s breast tissue. Read more
PMH clinicians map group at high risk for aggressive, hidden prostate cancer
October 8, 2009
from University Health Network
Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians – why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer? Read more
Analyzing Cancer Cells to Choose Treatments
September 30, 2009
Microfluidics chips allow scientists to study circulating cancer cells and determine their vulnerabilities.
By Emily Singer from MIT Technology Review
In a new clinical trial for prostate cancer, scientists will capture rare tumor cells circulating in patients’ blood, analyze them using a specialized microchip, and use the results to try to predict how well the patient will respond to a drug. The trial reflects a new phase of personalized medicine for cancer, enabled by microfluidics technologies that can isolate scarce cancer cells and detect very small changes in gene expression. Read more